Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07775196

Aging and Exercise Impacts on Glymphatic Function

Conditions: Aging and Exercise Impacts on Glymphatic Function

Sex: All
Ages: 25 Years – 75 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 240
Sponsor: University of Texas Southwestern Medical Center

Summary

This is a prospective, interventional, non-blinded, single center research project that will recruit cognitively unimpaired subjects in the 25-55 year old and 55-75 year old range. This study will use acute aerobic exercise as a natural intervention model to increase cardiac activity which may further drive the glymphatic function. There will be no randomization, and all enrolled subjects will participate in the exercise session. Hypotheses: revealed by the multi-modal magnetic resonance imaging (MRI) approach, glymphatic dysfunction increases with age and is associated with preclinical Alzheimer's Disease (AD) pathology in cognitively unimpaired individuals. Using acute aerobic exercise as a human model, the enhancement of cerebrospinal fluid-interstitial fluid (CSF-ISF) exchange caused by elevated cardiac activity and paravascular cerebrospinal fluid (pCSF) dynamics can be validated.

Eligibility Criteria

Inclusion Criteria: * age 25-75 years old * cognitively unimpaired (CU) * Mini-Mental State Examination (MMSE) score ≥27 at enrollment screening * matched gender * all racial/ethnic groups Exclusion Criteria: * pregnant women * history of stroke or other major cerebrovascular disease; * diagnosis of Alzheimer's disease (AD) or other types of dementia; * diagnosis of major neurologic and psychiatric disorders (e.g., Parkingson's disease, major depression); * history of prior head trauma, significant autoimmune disorders, * sleep apnea; * major systemic illness likely to affect the central nervous system, e.g., uncontrolled diabetes, severe cardiovascular disease, cancer, etc.; * prior or current alcoholism or drug abuse; * resistant hypertension (SBP ≥140 or DBP ≥ 90 mmHg despite 3 antihypertensive drugs at maximal doses); * orthostatic hypotension defined as the third standing systolic blood pressure (SBP) \< 100mmHg; any contraindications to having a MRI, e.g., claustrophobia, pacemaker or other medical device of metal; * any conditions judged by the investigators to be medically inappropriate, risky or likely to cause poor study compliance.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07775196). StuddyBuddy aggregates publicly available trial information.